ClearArc Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$601K Sell
2,744
-1,126
-29% -$247K 0.23% 105
2019
Q3
$656K Buy
3,870
+64
+2% +$10.8K 0.19% 134
2019
Q2
$698K Sell
3,806
-472
-11% -$86.6K 0.21% 117
2019
Q1
$787K Sell
4,278
-108
-2% -$19.9K 0.21% 113
2018
Q4
$727K Sell
4,386
-2,204
-33% -$365K 0.22% 112
2018
Q3
$1.27M Buy
6,590
+72
+1% +$13.9K 0.17% 132
2018
Q2
$1.11M Buy
6,518
+56
+0.9% +$9.52K 0.16% 147
2018
Q1
$1.05M Buy
6,462
+10
+0.2% +$1.63K 0.16% 147
2017
Q4
$967K Sell
6,452
-30
-0.5% -$4.5K 0.13% 159
2017
Q3
$986K Buy
6,482
+349
+6% +$53.1K 0.15% 148
2017
Q2
$790K Buy
6,133
+37
+0.6% +$4.77K 0.13% 180
2017
Q1
$667K Buy
6,096
+86
+1% +$9.41K 0.11% 194
2016
Q4
$443K Sell
6,010
-81
-1% -$5.97K 0.08% 259
2016
Q3
$531K Buy
6,091
+98
+2% +$8.54K 0.1% 226
2016
Q2
$516K Sell
5,993
-35
-0.6% -$3.01K 0.1% 223
2016
Q1
$479K Buy
6,028
+33
+0.6% +$2.62K 0.1% 231
2015
Q4
$754K Buy
5,995
+35
+0.6% +$4.4K 0.16% 158
2015
Q3
$621K Sell
5,960
-76
-1% -$7.92K 0.13% 206
2015
Q2
$745K Buy
6,036
+784
+15% +$96.8K 0.14% 192
2015
Q1
$620K Buy
5,252
+113
+2% +$13.3K 0.13% 201
2014
Q4
$611K Buy
5,139
+229
+5% +$27.2K 0.12% 196
2014
Q3
$551K Buy
4,910
+151
+3% +$16.9K 0.12% 199
2014
Q2
$451K Buy
4,759
+95
+2% +$9K 0.1% 226
2014
Q1
$330K Buy
4,664
+302
+7% +$21.4K 0.08% 279
2013
Q4
$324K Sell
4,362
-251
-5% -$18.6K 0.08% 259
2013
Q3
$350K Buy
+4,613
New +$350K 0.1% 233